Patent protection has been an incentive for promoting research and development of new drugs. While patent protection is desirable, it should not constitute a hindrance to access to essential drugs by Nigerians. Government shall, therefore, put in place strategies to ensure that public health interests are protected when trade matters conflict with health, especially in:
i. Securing coordination between health, justice and trade ministries to ensure that public health issues are taken into consideration in international negotiations;
ii. Developing mechanisms to monitor the effect of international trade agreements on Nigerians’ access to medicines; and
iii. Exploring existing mechanisms provided by international agreements to protect public health, especially those that affect access to affordable, good quality and essential drugs.